Table 2. A summary for positron emission tomography tracers used for glioma.
Chemical type | Tracer | Target or intake mechanism | Note |
18F: 18fluorine; 11C: 11carbon; FDG: fluorodeoxyglucose; LAT1: L-type amino acid transporter-1; MET: methyl-L-methionine; FET: O-(2-18F-fluoroethyl)-L-tyrosine; FDOPA: 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine; FLT: 3′-deoxy-3′-18F-fluorothymidine; CHO: choline; FHO: fluorocholine; FMISO: fluoromisonidazole; ASCT2: alanine-serine-cysteine-2; ACE: acetate; FAC: fluoroacetate; FPIA: fluoropivalic acid; FPP(RGD)2: 2-fluoropropionyl-labeled PEGylated dimeric RGD peptide; BBB: blood-brain-barrier. | |||
Glucose analogue | 18F-FDG | Glucose | Demonstrate glucose metabolism; Poor tumor-to-background contrast |
Amino-acid | 11C-MET[62–63,65–66] | LAT1 | Demonstrate amino-acid uptake; High sensitivity and specificity; Best and most studied tracers for glioma |
18F-FET[67–72] | |||
18F-FDOPA[73–76] | |||
Thymidine analog | 18F- FLT[77–82] | Thymidine kinase 1 | Markers of cell proliferation; Cannot pass intact BBB |
Choline | 11C-CHO[84–86,88] | Choline transporter | Monitor membrane phospholipids; Cannot pass intact BBB |
18F-FHO[83,86–87] | |||
Nitroimidazole | 18F-FMISO[89–90] | Nitroreductase enzymes | Investigate intratumoural hypoxia; Haven't achieved clinical relevance |
Amino acid | 18F-fluciclovine [92,94–96] | LAT1 & ASCT2 | Demonstrate amino-acid uptake; Transported by both LAT1 and ASCT2 |
Acetate | 11C-ACE[99–100] | Acetate/acetyl CoA metabolism | Demonstrate the use of fatty acid |
14C-ACE[101] | |||
18F-FAC[102] | |||
18F-FPIA[103] | |||
Peptide | 18F-FPP(RGD)2[104–106] | αvβ3-integrin | Demonstrate angiogenesis |